SCHEMBL17313627

SCHEMBL17313627

Brc1ccc2c(c1)Cc1ccccc1-2.O=S

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 2/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
SRD5A2 P31213 1/20 0.51
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 2/20 0.49
METAP1 P53582 1/20 0.49
HTR2C P28335 3/20 0.47
HTR2B P41595 2/20 0.47
HTR2A P28223 2/20 0.47
DRD2 P14416 1/20 0.47
ADRA1D P25100 1/20 0.47
HTR7 P34969 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL415882 0.94 ALDH1A1 (0.59) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL29466104 0.94 ALDH1A1 (0.59) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL29780658 0.94 ALDH1A1 (0.59) SMN1; SMN2RAB9AMAPTHPGDKDM4E
Fluorene SCHEMBL15453329 0.94 ALDH1A1 (0.59) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL17313628 0.92 L3MBTL1 (0.56) SMN1; SMN2RAB9AMAPTHPGDKDM4E
Ammonia Solution, Strong SCHEMBL665105 0.92 ALDH1A1 (0.57) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL23542831 0.86 L3MBTL1 (0.56) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL1806266 0.86 L3MBTL1 (0.56) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL19237245 0.86 L3MBTL1 (0.56) SMN1; SMN2RAB9AMAPTHPGDKDM4E
SCHEMBL29376113 0.83 METAP1 (0.57) SMN1; SMN2RAB9AMAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9397301-B2 Sulfone group-containing compound, an organic light emitting diode (OLED) device having the same, and a method of fabricating the OLED device SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) 2016-07-19 US disclosed
US-20150357584-A1 A Sulfone Group-Containing Compound, An Organic Light Emitting Diode (OLED) Device Using The Same, and A Method of Fabricating the OLED Device SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150357584-A1 A Sulfone Group-Containing Compound, An Organic Light Emitting Diode (OLED) Device Using The Same, and A Method of Fabricating the OLED Device OCIAD1, SULT1A1, STARD10 SMN1; SMN2 2887/4885RAB9A 1700/4885MAPT 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.